Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Contract Win and Managed Services Update

20 Dec 2017 07:00

RNS Number : 8361Z
Falanx Group Limited
20 December 2017
 

 

Falanx Group Limited

("Falanx" or "the Company")

 

Contract Win and Managed Services Update

 

Falanx (AIM:FLX), the global intelligence, security and cyber defence provider, announces a multi-year contract win with a Global 50 company.

 

Global 50 Financial Services Contract

 

The Board is pleased to announce that it has been appointed as the preferred supplier of cyber security services to a Global 50 Financial Services organisation, after a highly demanding and competitive selection process amongst numerous major cyber security vendors. The duration of the contract is for a minimum two year period. This initial phase is valued at circa £250,000 with significant growth potential and expansion opportunity into further territories.

 

 

 

MidGARD Managed Service Update

 

The MidGARD managed security service 'proof of concept' (POC) phase has been successfully completed on time, with commercial roll-out now in process. Clients are now being on-boarded to our industry leading platform which is comprised of our own intellectual property and third-party technologies. Early adopting clients are now converting to full implementation with more enterprise class clients in active negotiation to receive the full MidGARD service under multi-year contracts. The strong pipeline of potential clients provides the Board with high levels of assurance of doubling the number of current managed service clients within the next quarter. The MidGARD managed service benefits from high margin, strong cash generation and a significant level of automation. Annual contract values under such multi-year contracts are expected to be typically between £50,000 and £300,000 dependent on individual customer requirements and services delivered

 

 

Mike Read, Chairman and CEO, commented:

 

"Since taking over as CEO and conducting a far-reaching review of our business, I am pleased to report Falanx continues to grow and remains in-line with the Boards expectation to move into break even within our financial year.

 

The contract wins announced today provide visibility of high quality recurring revenue, which is further supported by our strong pipeline of MidGARD clients on-boarding now and in the future. 

 

I have taken measures to strengthen the Board and a new, full time, AIM experienced Financial Director will join the Board in January. I have also agreed with the Board to accept the appointment of Chief Executive Officer on a permanent basis as we look to the future with great confidence."

 

 

 

 

Enquiries:

 

Falanx Group Limited

Mike Read, Chairman and CEO

 

www.falanx.com

 

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis / James Keeshan

+44 (0) 203 368 3551

 

Turner Pope Investments (TPI) Ltd

Joint-Broker

Ben Turner / James Pope

 

Beaufort Securities

Joint-Broker

Elliot Hance

 

IFC Advisory Ltd

Financial PR & IR

Graham Herring

Miles Nolan

 

+44 (0) 203 621 4120

 

 

 

+44 (0) 207 382 8300

 

 

 

+44 (0) 203 934 6633

 

About Falanx

Falanx Group Limited, is a global intelligence and cyber defence provider working with blue chip and government clients. The Group listed on AIM in June 2013 under ticker FLX For more information: http://www.falanxgroup.com/

 

MAR

This announcement contains inside information for purposes of Article 7 of Regulation (EU) No 596/2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTTLBATMBTBBPR
Date   Source Headline
9th Dec 20222:42 pmRNSHolding(s) in Company
8th Dec 20224:29 pmRNSResult of AGM
8th Dec 20227:00 amRNSInterim Results
24th Nov 20225:17 pmRNSHolding(s) in Company
15th Nov 20225:56 pmRNSNotice of AGM
18th Oct 20227:00 amRNSDirectorate Change
29th Sep 20227:00 amRNSFinal Results
20th Sep 20227:00 amRNSHolding(s) in Company
5th Sep 20224:53 pmRNSHolding(s) in Company
4th Aug 20222:06 pmRNSSecond Price Monitoring Extn
4th Aug 20222:00 pmRNSPrice Monitoring Extension
4th Aug 202211:05 amRNSSecond Price Monitoring Extn
4th Aug 202211:00 amRNSPrice Monitoring Extension
4th Aug 20227:00 amRNSTrading Update
9th May 20227:00 amRNSPartnership to Provide M-EDR to UK Customers
8th Apr 20224:06 pmRNSHolding(s) in Company
6th Apr 202211:59 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSChange of Adviser
30th Mar 20222:44 pmRNSDirector/PDMR Shareholding
23rd Mar 202212:59 pmRNSDirector/PDMR Shareholding
10th Feb 202211:11 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSDirector/PDMR Shareholding
19th Jan 20225:20 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 202111:14 amRNSResult of AGM
7th Dec 20217:00 amRNSInterim Results
16th Nov 20212:10 pmRNSNotice of AGM
29th Oct 20211:57 pmRNSExercise of Options, TVR and PDMR dealing
27th Oct 20219:03 amRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSDirector/PDMR Shareholding
25th Oct 20213:25 pmRNSExercise of Options and TVR
13th Oct 202111:06 amRNSSecond Price Monitoring Extn
13th Oct 202111:00 amRNSPrice Monitoring Extension
13th Oct 20217:00 amRNSTrading update and BOOST&Co loan facility update
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20212:43 pmRNSSale of Assynt for £4.6 million
4th Oct 20217:00 amRNSFalanx Launch Mass Market Security Assessment Tool
29th Sep 20217:00 amRNSAnnual results for the year ended 31 March 2021
18th Aug 20217:01 amRNSGrant of share options
18th Aug 20217:00 amRNSTrading Update & New Loan Facility
9th Jul 20219:07 amRNSHolding(s) in Company
29th Apr 20217:00 amRNSCancellation of unapproved Share Options
1st Apr 20217:00 amRNSIssue of Equity and TVR
26th Feb 20213:31 pmRNSResult of GM
10th Feb 20212:03 pmRNSPublication of Circular & Notice of GM
8th Feb 202111:05 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSContract Wins and Covid Business Interruption Loan
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.